Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bispecific”

Showing 10 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07409454
What this trial is testing

MRD-Guided BCMA/CD3 Bispecific Antibody Treatment After Stem Cell Transplant for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 20
Early research (Phase 1)Looking for participantsNCT04762641
What this trial is testing

This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
ABL Bio, Inc. 100
Early research (Phase 1)UnknownNCT06166472
What this trial is testing

Evaluate the Safety, Tolerance, Pharmacokinetics, and Preliminary Antineoplastic Activity of AK132 in Advanced Malignant Solid Tumor

Who this might be right for
Advanced Malignant Solid Tumor
Akeso 72
Testing effectiveness (Phase 2)Looking for participantsNCT06840119
What this trial is testing

Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers

Who this might be right for
CancerHLA-A*02:01-positive
Immunocore Ltd 600
Early research (Phase 1)UnknownNCT05360381
What this trial is testing

HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid TumorsSquamous-cell Non-small Cell Lung Cancer
Shanghai Henlius Biotech 82
Testing effectiveness (Phase 2)Looking for participantsNCT07297212
What this trial is testing

A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
BioNTech SE 75
Testing effectiveness (Phase 2)Study completedNCT03070392
What this trial is testing

Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma

Who this might be right for
Uveal Melanoma
Immunocore Ltd 378
Early research (Phase 1)Active Not RecruitingNCT05338775
What this trial is testing

Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhibitor for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed/ Refractory Multiple Myeloma
Janssen Research & Development, LLC 74
Early research (Phase 1)Looking for participantsNCT07166601
What this trial is testing

M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 77
Large-scale testing (Phase 3)Not Yet RecruitingNCT07739199
What this trial is testing

A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Versus Chemotherapy in Combination With PD-1/VEGF Bispecific Antibody in First-line Patients With Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer(PANKU-Lung05)

Who this might be right for
Squamous Non-small-cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 200

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation